Silver Leaf Oak acquires 10% stake in Syngene

September 18, 2014 | Thursday | News | By BioSpectrum Bureau

Silver Leaf Oak acquires 10% stake in Syngene

(Photo Courtesy: www.proactiveinvestors.com)

(Photo Courtesy: www.proactiveinvestors.com)

Silver Leaf Oak (Mauritius) Limited, an investment vehicle advised by India Value Fund Advisors (IVFA) has agreed to acquire a minority 10% stake in Syngene International, Biocon's Research Services subsidiary.

Silver Leaf will acquire the stake from Biocon Research Limited (BRL), a wholly owned subsidiary of Biocon Limited at a valuation of Rs 3800 crore.

Biocon's shares was at Rs 499.95, up by Rs 13.15 or 2.7% at 1900hrs, on September 18, 2014.

The transaction is subject to standard condition precedents including regulatory approvals.

Post the completion of this transaction, Biocon and BRL will jointly hold 85.54% stake in Syngene.

 

The Biocon Group was advised by Allegro Advisors.

The lawyers for Biocon Group and Silver Leaf Oak were Wadia Ghandy and DSK Legal, respectively.

 

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy